| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $302M | — | $275M | — | 9.8% |
| Op. Income | $11M | — | -$4M | — | 393.5% |
| Gross Margin | 80.7% | — | 80.6% | — | 0.0pp |
| Net Margin | 6.7% | — | 2.2% | — | 4.5pp |
| EPS (Diluted) | $0.45 | — | $0.14 | — | 221.4% |
| Free Cash Flow | $42M | — | $66M | — | -37.4% |
| Item | Amount |
|---|---|
| REVENUE | $302M |
| Cost of Revenue | $58M |
| GROSS PROFIT | $244M |
| R&D Expenses | $79M |
| Selling & Marketing | $128M |
| General & Administrative | $26M |
| SG&A Expenses | $153M |
| Other Expenses | $0 |
| Operating Expenses | $232M |
| Cost & Expenses | $290M |
| OPERATING INCOME | $11M |
| Interest Income | $15M |
| Interest Expense | $0 |
| Other Income/Expenses | $18M |
| INCOME BEFORE TAX | $29M |
| Income Tax Expense | $9M |
| Net Income from Continuing Ops | $20M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $20M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $20M |
| D&A | $12M |
| EBIT | $11M |
| EBITDA | $23M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $302M |
| Cost of Revenue | $58M |
| GROSS PROFIT | $244M |
| R&D Expenses | $79M |
| Selling & Marketing | $128M |
| General & Administrative | $26M |
| SG&A Expenses | $153M |
| Other Expenses | $0 |
| Operating Expenses | $232M |
| Cost & Expenses | $290M |
| OPERATING INCOME | $11M |
| Interest Income | $15M |
| Interest Expense | $0 |
| Other Income/Expenses | $18M |
| INCOME BEFORE TAX | $29M |
| Income Tax Expense | $9M |
| Net Income from Continuing Ops | $20M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $20M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $20M |
| D&A | $12M |
| EBIT | $11M |
| EBITDA | $23M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $20M |
| Depreciation & Amortization | $12M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $32M |
| Change in Working Capital | -$14M |
| OPERATING CASH FLOW | $50M |
| Capital Expenditure | -$9M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$22M |
| NET CASH FROM INVESTING | -$30M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$10M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$3M |
| NET CASH FROM FINANCING | -$14M |
| FREE CASH FLOW | $42M |
| Net Change in Cash | $6M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $105M |
| Short-Term Investments | $152M |
| Net Receivables | $35M |
| Inventory | $13M |
| Other Current Assets | $11M |
| TOTAL CURRENT ASSETS | $317M |
| PP&E (Net) | $32M |
| Goodwill | $68M |
| Intangible Assets | $8M |
| Long-Term Investments | $206M |
| Tax Assets | $0 |
| Other Non-Current Assets | $41M |
| TOTAL NON-CURRENT ASSETS | $355M |
| TOTAL ASSETS | $671M |
| Account Payables | $7M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $181M |
| TOTAL CURRENT LIABILITIES | $194M |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $75M |
| TOTAL NON-CURRENT LIABILITIES | $87M |
| TOTAL LIABILITIES | $280M |
| Common Stock | $770.0K |
| Additional Paid-In Capital | $579M |
| Retained Earnings | $146M |
| Treasury Stock | -$378M |
| Accum. Other Comp. Income | $1M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $349M |
| Minority Interest | $41M |
| TOTAL EQUITY | $391M |
| TOTAL LIABILITIES & EQUITY | $671M |
| Total Debt | $17M |
| Net Debt | -$88M |
